The largest database of trusted experimental protocols

26 protocols using api 4000 mass spectrometer

1

Quantification of Urinary and Plasma GAGs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrations of urinary and plasma GAGs and KS were measured by tandem mass spectroscopy as described elsewhere (16 (link)). Briefly, the chromatographic system consists of an HP1100 system (Agilent Technologies) and a Hypercarb column (Thermo Electron). The API-4000 mass spectrometer (Applied Biosystems) was equipped with a turbo ionspray ion source. Disaccharides of keratan, heparan, dermatan sulfate were used as standards [Galß1,4GlcNAc(6S), ΔDiHS-0S, ΔDiHS-NS, ΔDi-4S, ΔDi-6S (Seikagaku). Chondrosine was used as internal standard (Glycosyn). Urine or plasma was centrifuged, and the supernatants were digested overnight with 1 mU of chondroitinase b, 1mU heparitinase, and 1mU keratanase II (Seikagaku). Recovered samples were analyzed by the LC-MS/MS system and normalized by creatinine concentration in urine. Total GAGs refer to total glycosaminoglycans or the additive sum of all the GAGs measured (HS, DS and KS). Disaccharide GAG concentrations were calculated by Analyst 1.5.1 software (AB SCIEX). Each sample was measured in triplicate with three injections for each sample.
+ Open protocol
+ Expand
2

MDCK-mdr1 Cell Transwell Assay for Drug Transport

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDCK-mdr1 cells obtained from the Netherlands Cancer Institute were grown on Transwell type filters (Corning) for 4 days to confluence in DMEM/F12 media containing 10% fetal bovine serum and antibiotics. Compounds were added to the apical side at a concentration of 10 μM in a transport buffer comprising of 1X Hank’s balanced salt solution, 25 mM D-glucose and buffered with HEPES to pH 7.4. Samples were incubated for 1 h at 37 °C and carefully collected from both the apical and basal side of the filters. Compounds selected for MDCK-mdr1 cell assays were infused on an Applied Biosystems API-4000 mass spectrometer to optimize for analysis using multiple reaction monitoring (MRM), as previously described.33 (link) The chromatography was conducted with an Agilent 1100 binary pump with a flow rate of 0.5 mL/min. Mobile phase solvents were 0.1% formic acid in water (A) and 0.1% formic acid in methanol (B). The solvent conditions were 10% B for 1 min, followed by a gradient to 95% B over 5 min. Data reported are average values from 2–3 measurements.
+ Open protocol
+ Expand
3

MDCK-mdr1 Cell Transport Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDCK-mdr1 cells obtained from The Netherlands Cancer Institute were grown on Transwell type filters (Corning) for 4 d to confluence in DMEM/F12 media containing 10% fetal bovine serum and antibiotics as has been described previously.36 (link),37 (link) Compounds were added to the apical side at a concentration of 10 μM in a transport buffer comprising 1× Hank’s balanced salt solution, 25 mM d-glucose, and buffered with HEPES to pH 7.4. Samples were incubated for 1 h at 37 °C and carefully collected from both the apical and basal side of the filters. Compounds selected for MDCK-mdr1 cell assays were infused on an Applied Biosystems API-4000 mass spectrometer to optimize for analysis using multiple reaction monitoring (MRM). Flow injection analysis was also conducted to optimize for mass spectrometer parameters. Samples from the apical and basolateral side of the MDCK cell assay were dried under nitrogen on a Turbovap LV. The chromatography was conducted with an Agilent 1100 binary pump with a flow rate of 0.5 mL/min. Mobile phase solvents were A, 0.1% formic acid in water, and B, 0.1% formic acid in methanol. The initial solvent conditions were 10% B for 1 min, then a gradient was used by increasing to 95% B over 5 min, then returning to initial conditions. Data reported are average values from 2 to 3 measurements.
+ Open protocol
+ Expand
4

Transwell Transport Assay for MDCK-mdr1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDCK-mdr1 cells obtained from The Netherlands Cancer Institute were grown on Transwell type filters (Corning) for 4 d to confluence in DMEM/F12 media containing 10% fetal bovine serum and antibiotics. Compounds were added to the apical side at a concentration of 10 μM in a transport buffer comprised of 1× Hank’s balanced salt solution, 25 mM d-glucose and buffered with HEPES to pH 7.4. Samples were incubated for 1 h at 37 °C and carefully collected from both the apical and basal sides of the filters. Compounds selected for MDCK-mdr1 cell assays were infused on an Applied Biosystems API-4000 mass spectrometer to optimize for analysis using multiple reaction monitoring (MRM), as previously described.39 (link) The chromatography was conducted with an Agilent 1100 binary pump with a flow rate of 0.5 mL/min. The mobile phase solvents were 0.1% formic acid in water (A) and 0.1% formic acid in methanol (B). The solvent conditions were 10% B for 1 min, followed by a gradient to 95% B over 5 min. Data reported are average values from two to three measurements.
+ Open protocol
+ Expand
5

Montelukast Quantification by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
 An Applied Biosystems API4000 mass spectrometer was used with turbo ion spray and positive ionization. Mass ratios were 586.4/422.1 amu for montelukast, 592.3/427.1 amu for the motelukast standard, 602.4/438.0 amu for montelukast 1,2‐diol, and for hydroxybupropion, and 592.3/427.1 amu for the montelukast 1,2‐diol standard.
+ Open protocol
+ Expand
6

MDCK-mdr1 Transwell Transport Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDCK-mdr1 cells obtained from The Netherlands Cancer Institute were grown on Transwell-type filters (Corning) for 4 days to confluence in DMEM/F12 media containing 10% fetal bovine serum and antibiotics. Compounds were added to the apical sides at concentrations of 10 μM in a transport buffer comprising 1× Hank’s balanced salt solution with 25 mM d-glucose and buffered with HEPES to pH 7.4. The samples were incubated for 1 h at 37 °C and carefully collected from both the apical and basal sides of the filters. The compounds selected for the MDCK-mdr1 cell assays were infused on an Applied Biosystems API-4000 mass spectrometer in order to optimize them for analysis using multiple-reaction monitoring (MRM), as previously described.27 (link) Chromatography was conducted with an Agilent 1100 binary pump with a flow rate of 0.5 mL/min. The mobile-phase solvents were 0.1% formic acid in water (A) and 0.1% formic acid in methanol (B). The solvent conditions were 10% B for 1 min, followed by a gradient to 95% B over 5 min. The data reported are average values from two to three measurements.
+ Open protocol
+ Expand
7

Characterization of MβCD Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify the average molecular weight and levels of methylation in side chains of MβCD molecules, we carried out the MS analysis. Initially, 0.4 mg of MβCD powder was dissolved in 3 mL of deionized Millipore (Sigma-Aldrich, St. Louis, MO) water as the stock solution (100 μM). An aliquot of the MβCD stock solution was further diluted with 90% methanol to 10 μg/mL (8 μM) for MS analysis. The diluted MβCD solution was directly infused into the API-4000 Mass Spectrometer (Applied Biosystems, Forster City, CA) at a rate of 10 μL/min. The mass spectrometer was used for Q1 scan with positive ion electrospray mode at 5000V and 100V declustering potential. The MS scan range was adjusted from m/z 1,200 to 1,450 at a scan rate of 2 s. The data analysis was performed by Analyst 1.5.1 software (Applied Biosystems, Foster City, CA).
+ Open protocol
+ Expand
8

Serum 25(OH)D3 Quantification by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were stored at −70°C. Reagents, including methanol, methyl cyanides, n-hexane and anhydrous ethanol (Merck KGaA, Darmstadt, Germany), standard substance (SRM972, Sigma-Aldrich, St. Louis, MO, USA), internal standard product (Advanced Medical Isotopes Corporation, Kennewick, WA, USA) and quality control (RECIPE, Munich, Germany). Serum 25(OH)D3 levels were measured by liquid chromatography-tandem mass spectrometry on an API 4000 mass spectrometer (Applied Biosystems Life Technologies, Foster City, CA, USA) in the Jinyu Medical Test Center (Guangzhou, China).
+ Open protocol
+ Expand
9

In Vitro PK Assay for LDT5

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay was performed as part of the routine in vitro PK assays,
even knowing that LDT5 (a monohydrochloride salt) was highly water soluble. The study
was performed in a 96-deep well plate by spiking 10 µL of working stock solutions to
990 µL of 50 mM sodium phosphate buffer, pH 7.4. After 2 h, the plate was centrifuged
at 1,000 g for 20 min at room temperature and aliquots were
withdrawn from the supernatant and diluted 1:1 with acetonitrile for analysis by a
validated LC-MS/MS detection method using labetalol as an internal standard, a BDS
Hypersil Phenyl (150*4.6, 5 µm) column and a mobile phase composed of 5 mM ammonium
formate:acetonitrile (40:60, % v/v) with 0.05% formic acid. An API 4000 mass
spectrometer (Applied Biosystems/MDS SCIEX, Canada) was used for detection in a
positive ionization mode and with the following MRM transitions: 357.4→165.2 and
329.2→162 for LDT5 and labetolol, respectively.
+ Open protocol
+ Expand
10

Measurement of PFAS in Serum Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
We measured eight PFAS using a modification of a published method (Kuklenyik et al. 2005 (link)) [current acronyms (Buck et al. 2011 (link)) followed by previously used acronyms as applies in parentheses: perfluorooctane sulfonamide (FOSA/PFOSA), 2-(N-ethylperfluorooctane sulfonamido) acetate (Et-FOSAA/Et-PFOSA-AcOH), 2-(N-methyl-perfluorooctane sulfonamido) acetate (Me-FOSAA/Me-PFOSA-AcOH), perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), PFOA, perfluo-rononanoate (PFNA), and perfluorodecanoate (PFDA/PFDeA)]. Briefly, isotope-labeled internal standards were used for quantification. To compensate for the lack of isotope-labeled internal standard for PFHxS and to account for potential matrix effects, we spiked the calibration standards into calf serum. Analyte concentrations were detected by negative-ion TurboIonSpray–tandem mass spectrometry on an API 4,000 mass spectrometer (Applied Biosystems, Foster City, CA). The limits of detection (LODs) were 0.08ng/mL (PFNA), 0.1ng/mL (PFOSA, Et-PFOSA-AcOH, PFHxS, PFOA), and 0.2ng/mL (PFOS, Me-PFOSA-AcOH, PFDeA). Low-concentration quality control materials (QCs) and high-concentration QCs, prepared from a calf serum pool, were analyzed with the unknown samples and with reagent and serum blanks to ensure the accuracy and reliability of the data (Kuklenyik et al. 2005 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!